Syringe Maker Faces Securities Suit Amid Whistleblower Row

Law360, Los Angeles (November 1, 2013, 7:45 PM EDT) -- Unilife Corp., a developer and supplier of injectable drug delivery systems, was hit with a putative securities class action in Pennsylvania federal court Friday by an investor who says Unilife's top executives' false statements about the company's prospects were revealed by a whistleblower who sued for wrongful termination.

The lawsuit raises allegations that the defendants misled investors about demand for the product, the fact that Unilife's Unifill syringes and quality management system failed to comply with the U.S. Food and Drug Administration's regulations and other issues. The information came to light when a former Unilife employee sued the company Aug. 30...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!